FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386979007: Cabergoline (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461157016 Cabergoline (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481093014 Cabergoline en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
59001000195116 cabergolina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
192631000077110 cabergoline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
74171000195113 Cabergolin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline (substance) Is a Dopamine agent false Inferred relationship Some
Cabergoline (substance) Is a classe d'allergènes false Inferred relationship Some
Cabergoline (substance) Is a allergène médicamenteux false Inferred relationship Some
Cabergoline (substance) Is a Antiparkinsonian agent (substance) true Inferred relationship Some
Cabergoline (substance) Is a Dopamine receptor agonist true Inferred relationship Some
Cabergoline (substance) Is a Ergoline derivative (substance) true Inferred relationship Some
Cabergoline (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Dopamine receptor agonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing cabergoline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline (substance) Inferred relationship Some 1
Cabergoline adverse reaction Causative agent (attribute) True Cabergoline (substance) Inferred relationship Some 1
Allergy to cabergoline (finding) Causative agent (attribute) False Cabergoline (substance) Inferred relationship Some
Cabergoline [parkinsons] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some
Cabergoline 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some
Cabergoline 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some
Cabergoline 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some
Cabergoline 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some
Cabergoline 0.5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some
Allergy to cabergoline (finding) Causative agent (attribute) True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some 1
Cabergoline 1 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some 1
Cabergoline 2 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 4 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some 1
Cabergoline 4 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cabergoline (substance) Inferred relationship Some 1
Cabergoline 500 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 500 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 1 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 2 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabergoline (substance) Inferred relationship Some 1
Cabergoline 4 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabergoline (substance) Inferred relationship Some 1
Product containing cabergoline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline (substance) Inferred relationship Some 1
Product containing only cabergoline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline (substance) Inferred relationship Some 1
Product containing only cabergoline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cabergoline (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start